BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7244366)

  • 1. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of murine L1210 leukemia and bone marrow progenitor cells against mechlorethamine and inhibition of choline uptake as a structure-activity relationship of 2-dimethylaminoethanol and its analogues.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    J Pharm Sci; 1984 Jan; 73(1):34-9. PubMed ID: 6694079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraalkylammonium ions: protection of murine L1210 leukemia and bone marrow progenitor cells in vitro against mechlorethamine cytotoxicity and inhibition of the choline transport system.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    Chem Biol Interact; 1982 Jun; 40(2):133-40. PubMed ID: 7083390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ethanolamine and choline on thiotepa cellular accumulation and cytotoxicity in L1210 cells.
    Egorin MJ; Snyder SW; Wietharn BE
    Cancer Res; 1990 Jul; 50(14):4322-7. PubMed ID: 2114213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells.
    Scanlon KJ; Safirstein RL; Thies H; Gross RB; Waxman S; Guttenplan JB
    Cancer Res; 1983 Sep; 43(9):4211-5. PubMed ID: 6683587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK; Huang AT; Joines WT
    Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
    Xuan Y; Hacker MP; Tritton TR; Bhushan A
    Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of melphalan by sensitive and resistant L1210 cells.
    Redwood WR; Colvin M
    Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of cytarabine uptake and toxicity by dipyridamole.
    King ME; Naporn A; Young B; Howell SB
    Cancer Treat Rep; 1984 Feb; 68(2):361-6. PubMed ID: 6697325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells.
    Zhao R; Gao F; Goldman ID
    Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1512-7. PubMed ID: 11997266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T; Szmigielska A
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lithium on the myelosuppressive and chemotherapeutic activities of vinblastine.
    Cass CE; Turner AR; Selner M; Allalunis MJ; Tan TH
    Cancer Res; 1981 Mar; 41(3):1000-5. PubMed ID: 7459846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.